Literature DB >> 30760087

Compositional changes to the ileal microbiome precede the onset of spontaneous ileitis in SHIP deficient mice.

Peter Allan Dobranowski1,2, Chris Tang1, Jean Philippe Sauvé1,2, Susan Christine Menzies1,2, Laura May Sly1,2.   

Abstract

Inflammatory bowel disease, encompassing both ulcerative colitis and Crohn's disease, is characterized by chronic, relapsing-remitting gastrointestinal inflammation of unknown etiology. SHIP deficient mice develop fully penetrant, spontaneous ileitis at 6 weeks of age, and thus offer a tractable model of Crohn's disease-like inflammation. Since disruptions to the microbiome are implicated in the pathogenesis of Crohn's disease, we conducted a 16S rRNA gene survey of the ileum, cecum, colon, and stool contents of SHIP+/+ and SHIP-/- mice. We predicted that diversity and compositional changes would occur after, and possibly prior to, the onset of overt disease. No differences were found in alpha diversity, but significant changes in beta diversity and specific commensal populations were observed in the ileal compartment of SHIP deficient mice after the onset of overt disease. Specifically, reductions in the Bacteroidales taxa, Muribaculum intestinale, and an expansion in Lactobacillus were most notable. In contrast, expansions to bacterial taxa previously associated with inflammation, including Bacteroides, Parabacteroides, and Prevotella were observed in the ilea of SHIP deficient mice prior to the onset of overt disease. Finally, antibiotic treatment reduced the development of intestinal inflammation in SHIP-/- mice. Thus, our findings indicate that SHIP is involved in maintaining ileal microbial homeostasis. These results have broader implications for humans, since reduced SHIP protein levels have been reported in people with Crohn's disease.

Entities:  

Keywords:  Crohn’s disease; SHIP; ileitis; intestinal inflammation; microbiome

Mesh:

Substances:

Year:  2019        PMID: 30760087      PMCID: PMC6748580          DOI: 10.1080/19490976.2018.1560767

Source DB:  PubMed          Journal:  Gut Microbes        ISSN: 1949-0976


  78 in total

1.  Compositional Changes in the Gut Mucus Microbiota Precede the Onset of Colitis-Induced Inflammation.

Authors:  Maria Glymenaki; Gurdeep Singh; Andrew Brass; Geoffrey Warhurst; Andrew J McBain; Kathryn J Else; Sheena M Cruickshank
Journal:  Inflamm Bowel Dis       Date:  2017-06       Impact factor: 5.325

2.  Sulfate-reducing bacteria in human feces and their association with inflammatory bowel diseases.

Authors:  Julien Loubinoux; Jean-Pierre Bronowicki; Ines A C Pereira; Jean-Louis Mougenel; Alain E Faou
Journal:  FEMS Microbiol Ecol       Date:  2002-05-01       Impact factor: 4.194

3.  Multiple pathways involved in the biosynthesis of anandamide.

Authors:  Jie Liu; Lei Wang; Judith Harvey-White; Bill X Huang; Hee-Yong Kim; Serge Luquet; Richard D Palmiter; Gerald Krystal; Ravi Rai; Anu Mahadevan; Raj K Razdan; George Kunos
Journal:  Neuropharmacology       Date:  2007-06-06       Impact factor: 5.250

4.  Host and microbiota interactions are critical for development of murine Crohn's-like ileitis.

Authors:  M Roulis; G Bongers; M Armaka; T Salviano; Z He; A Singh; U Seidler; C Becker; J Demengeot; G C Furtado; S A Lira; G Kollias
Journal:  Mucosal Immunol       Date:  2015-10-21       Impact factor: 7.313

5.  Dysbiotic gut microbiota causes transmissible Crohn's disease-like ileitis independent of failure in antimicrobial defence.

Authors:  Monika Schaubeck; Thomas Clavel; Jelena Calasan; Ilias Lagkouvardos; Sven Bastiaan Haange; Nico Jehmlich; Marijana Basic; Aline Dupont; Mathias Hornef; Martin von Bergen; André Bleich; Dirk Haller
Journal:  Gut       Date:  2015-04-17       Impact factor: 23.059

6.  Dysbiosis, inflammation, and response to treatment: a longitudinal study of pediatric subjects with newly diagnosed inflammatory bowel disease.

Authors:  Kelly A Shaw; Madeline Bertha; Tatyana Hofmekler; Pankaj Chopra; Tommi Vatanen; Abhiram Srivatsa; Jarod Prince; Archana Kumar; Cary Sauer; Michael E Zwick; Glen A Satten; Aleksandar D Kostic; Jennifer G Mulle; Ramnik J Xavier; Subra Kugathasan
Journal:  Genome Med       Date:  2016-07-13       Impact factor: 11.117

7.  Meta-analysis of gut microbiome studies identifies disease-specific and shared responses.

Authors:  Claire Duvallet; Sean M Gibbons; Thomas Gurry; Rafael A Irizarry; Eric J Alm
Journal:  Nat Commun       Date:  2017-12-05       Impact factor: 14.919

8.  Chemical and pathogen-induced inflammation disrupt the murine intestinal microbiome.

Authors:  Mikayla A Borton; Anice Sabag-Daigle; Jikang Wu; Lindsey M Solden; Bridget S O'Banion; Rebecca A Daly; Richard A Wolfe; Juan F Gonzalez; Vicki H Wysocki; Brian M M Ahmer; Kelly C Wrighton
Journal:  Microbiome       Date:  2017-04-27       Impact factor: 14.650

9.  Multiple sclerosis patients have a distinct gut microbiota compared to healthy controls.

Authors:  Jun Chen; Nicholas Chia; Krishna R Kalari; Janet Z Yao; Martina Novotna; M Mateo Paz Soldan; David H Luckey; Eric V Marietta; Patricio R Jeraldo; Xianfeng Chen; Brian G Weinshenker; Moses Rodriguez; Orhun H Kantarci; Heidi Nelson; Joseph A Murray; Ashutosh K Mangalam
Journal:  Sci Rep       Date:  2016-06-27       Impact factor: 4.379

10.  The Artificial Sweetener Splenda Promotes Gut Proteobacteria, Dysbiosis, and Myeloperoxidase Reactivity in Crohn's Disease-Like Ileitis.

Authors:  Alexander Rodriguez-Palacios; Andrew Harding; Paola Menghini; Catherine Himmelman; Mauricio Retuerto; Kourtney P Nickerson; Minh Lam; Colleen M Croniger; Mairi H McLean; Scott K Durum; Theresa T Pizarro; Mahmoud A Ghannoum; Sanja Ilic; Christine McDonald; Fabio Cominelli
Journal:  Inflamm Bowel Dis       Date:  2018-04-23       Impact factor: 5.325

View more
  18 in total

1.  Temporal and region-specific effects of sleep fragmentation on gut microbiota and intestinal morphology in Sprague Dawley rats.

Authors:  Judy Triplett; David Ellis; Amber Braddock; Erin Roberts; Katherine Ingram; Eric Perez; Amanda Short; Dominique Brown; Victoria Hutzley; Chelsey Webb; Armando Soto; Victor Chan
Journal:  Gut Microbes       Date:  2020-01-10

2.  Changes in the gut microbiota: a possible factor influencing peripheral blood immune indexes in non-obese diabetic mice.

Authors:  Yiling Wu; Qi You; Jingjin Fei; Jie Wu
Journal:  Antonie Van Leeuwenhoek       Date:  2021-08-09       Impact factor: 2.271

3.  The reduction of DSS-induced colitis severity in mice exposed to cigarette smoke is linked to immune modulation and microbial shifts.

Authors:  Giuseppe Lo Sasso; Blaine W Phillips; Alain Sewer; James N D Battey; Athanasios Kondylis; Marja Talikka; Bjoern Titz; Emmanuel Guedj; Dariusz Peric; David Bornand; Remi Dulize; Celine Merg; Maica Corciulo; Sonia Ouadi; Rendy Yanuar; Ching Keong Tung; Nikolai V Ivanov; Manuel C Peitsch; Julia Hoeng
Journal:  Sci Rep       Date:  2020-03-02       Impact factor: 4.379

4.  Dehydroandrographolide inhibits mastitis by activating autophagy without affecting intestinal flora.

Authors:  Wenjin Guo; Juxiong Liu; Yufei Zhang; He Ma; Yuhang Li; Qian Gong; Yu Cao; Guiqiu Hu; Shengnan Xie; Shoupeng Fu
Journal:  Aging (Albany NY)       Date:  2020-07-23       Impact factor: 5.682

Review 5.  Harnessing murine models of Crohn's disease ileitis to advance concepts of pathophysiology and treatment.

Authors:  Lida Iliopoulou; George Kollias
Journal:  Mucosal Immunol       Date:  2021-07-27       Impact factor: 7.313

6.  (S)-Reutericyclin: Susceptibility Testing and In Vivo Effect on Murine Fecal Microbiome and Volatile Organic Compounds.

Authors:  Bernhard Kienesberger; Beate Obermüller; Georg Singer; Barbara Mittl; Reingard Grabherr; Sigrid Mayrhofer; Stefan Heinl; Vanessa Stadlbauer; Angela Horvath; Wolfram Miekisch; Patricia Fuchs; Ingeborg Klymiuk; Holger Till; Christoph Castellani
Journal:  Int J Mol Sci       Date:  2021-06-15       Impact factor: 5.923

7.  Intermittent cafeteria diet identifies fecal microbiome changes as a predictor of spatial recognition memory impairment in female rats.

Authors:  Sarah-Jane Leigh; Nadeem O Kaakoush; Michael J Bertoldo; R Frederick Westbrook; Margaret J Morris
Journal:  Transl Psychiatry       Date:  2020-01-27       Impact factor: 6.222

Review 8.  Links Between Inflammatory Bowel Disease and Chronic Obstructive Pulmonary Disease.

Authors:  April L Raftery; Evelyn Tsantikos; Nicola L Harris; Margaret L Hibbs
Journal:  Front Immunol       Date:  2020-09-11       Impact factor: 7.561

9.  The Effects of Prebiotic Supplementation with OMNi-LOGiC® FIBRE on Fecal Microbiome, Fecal Volatile Organic Compounds, and Gut Permeability in Murine Neuroblastoma-Induced Tumor-Associated Cachexia.

Authors:  Beate Obermüller; Georg Singer; Bernhard Kienesberger; Ingeborg Klymiuk; Daniela Sperl; Vanessa Stadlbauer; Angela Horvath; Wolfram Miekisch; Peter Gierschner; Reingard Grabherr; Hans-Jürgen Gruber; Maria D Semeraro; Holger Till; Christoph Castellani
Journal:  Nutrients       Date:  2020-07-08       Impact factor: 5.717

10.  Inhibitory Effects of Breast Milk-Derived Lactobacillus rhamnosus Probio-M9 on Colitis-Associated Carcinogenesis by Restoration of the Gut Microbiota in a Mouse Model.

Authors:  Haiyan Xu; Keizo Hiraishi; Lin-Hai Kurahara; Yuko Nakano-Narusawa; Xiaodong Li; Yaopeng Hu; Yoko Matsuda; Heping Zhang; Katsuya Hirano
Journal:  Nutrients       Date:  2021-03-30       Impact factor: 5.717

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.